+49 (0) 6172 608-2485
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
Director External Communications
T: +49 (0) 6172 608-2115
Manager External Communications
T: +49 (0) 6172 608-4030
View this post on Instagram
@freseniuskabi has opened a new state-of-the-art #compounding center in #Canada 🇨🇦. It involves an #investment of 11 million Canadian dollars (more than €7 million) 💰, and the new site expands the company’s presence in #Mississauga, Ontario. Fresenius Kabi is responding to increasing demand for large batches of compounded #medications for patients in Canadian #hospitals 🏥, and the 35,000-square-foot (3,300-square-meter) compounding center has the capacity to expand. The new facility is expected to employ 70 people 👩🔬👨🔬 by 2022.
A post shared by Fresenius (@fresenius.group) on
Fresenius SE & Co. KGaA
61352 Bad Homburg v.d.H.
T +49 (0) 6172 608-0